Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries (Q38209914)

31 August 2017

title

Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries (English)

1 reference

31 August 2017

0 references

5

1 reference

31 August 2017

Brian H Harvey

3

0 references

author name string

Justin Davis

series ordinal

1

1 reference

31 August 2017

Steven Moylan

series ordinal

2

1 reference

31 August 2017

Michael Maes

series ordinal

4

1 reference

31 August 2017

publication date

6 May 2014

1 reference

Australian and New Zealand Journal of Psychiatry

31 August 2017

published in

1 reference

31 August 2017

volume

48

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

512-529

1 reference

Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Regulation of GABAergic inputs to CA1 pyramidal neurons by nicotinic receptors and kynurenic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The cystine-glutamate transporter enhancer N-acetyl-L-cysteine attenuates cocaine-induced changes in striatal dopamine but not self-administration in squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Moderate iron deficiency in infancy: biology and behavior in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Nitric oxide and schizophrenia: present knowledge and emerging concepts of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Oxidative stress in schizophrenia: An integrated approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Effects of prenatal infection on brain development and behavior: a review of findings from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The neurobiology of schizophrenia: new leads and avenues for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Effect of olanzapine treatment on platelet glutamine synthetase-like protein and glutamate dehydrogenase immunoreactivity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The neurochemical circuitry of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Oxidative stress and neopterin abnormalities in schizophrenia: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Redox modulation of the NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Longitudinal progression of frontal and temporal lobe changes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Anatomical abnormalities in gray and white matter of the cortical surface in persons with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Stress and the progression of the developmental hypothesis of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Maternal Intrauterine Infection, Cytokines, and Brain Damage in the Preterm Newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Minocycline: therapeutic potential in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Valproate induces replication-independent active DNA demethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Isoprostenes as indicators of oxidative stress in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Putative neuroprotective agents in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Degree of fetal growth restriction associated with schizophrenia risk in a national cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The nature of relapse in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Mitochondrial diseases mimicking neurotransmitter defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Epigenetic and post-transcriptional dysregulation of gene expression in schizophrenia and related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Dendritic spine pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Epigenetic GABAergic targets in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Transcriptional regulation of hepatic fatty acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The dopamine hypothesis of schizophrenia: version III--the final common pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The nature of dopamine dysfunction in schizophrenia and what this means for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Epigenetic profiling in schizophrenia and major mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Localized gray matter volume reductions in the pars triangularis of the inferior frontal gyrus in individuals at clinical high-risk for psychosis and first episode for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Regional brain atrophy and functional disconnection in Broca's area in individuals at ultra-high risk for psychosis and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Half a century of antipsychotics and still a central role for dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Neuroprotective agents in schizophrenia and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Asymmetry of lexico-semantic processing in schizophrenia changes with disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

5-HT(1A) receptor dysfunction in female patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The metabolic syndrome in schizophrenia: is inflammation a contributing cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Cortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Perisomatic inhibition and cortical circuit dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Cortical gray matter volume deficit in patients with first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

In vivo immunomodulatory effects of clozapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Increased complement classical and mannan-binding lectin pathway activities in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Winter/summer seasonal changes in malondialdehyde formation as a source of variance in oxidative stress schizophrenia research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Relationship between inflammation and metabolic syndrome following treatment with paliperidone for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Analysis of coding-polymorphisms in NOTCH-related genes reveals NUMBL poly-glutamine repeat to be associated with schizophrenia in Brazilian and Danish subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Electrophysiological correlates of peroxide damage in guinea pig hippocampus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Stress and plasticity in the limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Genome-wide association study identifies five new schizophrenia loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Increased cortical kynurenate content in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Regulation of gamma-aminobutyric acid/barbiturate receptor-gated chloride ion flux in brain vesicles by phospholipase A2: possible role of oxygen radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Modality specific neural correlates of auditory and somatic hallucinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Inhibitory interneurons, oxidative stress, and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The cellular and behavioral consequences of interleukin-1 alpha penetration through the blood-brain barrier of neonatal rats: a critical period for efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The course of brain abnormalities in schizophrenia: can we slow the progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Hippocampal and amygdala volume reductions in first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Spatial characteristics of white matter abnormalities in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Dopamine and serotonin levels following prenatal viral infection in mouse--implications for psychiatric disorders such as schizophrenia and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Gamma oscillation deficits and the onset and early progression of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: possible relevance to neuroprotective interventions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

White matter deficits in first episode schizophrenia: an activation likelihood estimation meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Biochemical and functional interaction of disrupted-in-schizophrenia 1 and amyloid precursor protein regulates neuronal migration during mammalian cortical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

The myth of schizophrenia as a progressive brain disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

BDNF gene variants and brain morphology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Effect of Chronic N-Acetyl Cysteine Administration on Oxidative Status in the Presence and Absence of Induced Oxidative Stress in Rat Striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867414533012

21 January 2018

Identifiers

DOI

10.1177/0004867414533012

1 reference

31 August 2017

1 reference